Chesnara (CSN) H2 2023 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2023 earnings summary
31 Oct, 2026Executive summary
Delivered £53.0m commercial cash generation, £59.1m ECV earnings and a 205% Solvency II ratio; total dividend increased 3% to 23.97p per share, marking 19 consecutive annual increases.
Strategic priorities remain growing existing business value, disciplined life and pensions acquisitions, and profitable new business; two transactions were completed during 2023 and the acquisition pipeline remained positive entering 2024.
Financial highlights
Commercial cash generation was £53.0m versus £46.6m in FY 2022; base cash generation was £32.5m versus £82.7m.
Closing ECV was £524.7m versus £511.7m; ECV earnings were £59.1m versus a loss of £84.7m, including day-one acquisition gains and excluding FX impacts and dividend payments.
IFRS profit before tax was £1.8m versus a £62.1m loss; profit after tax was £18.7m versus a £33.7m loss.
Commercial VNB was £10.1m versus £9.5m; FUM rose to £11.5bn from £10.6bn.
IFRS capital base increased to £487.4m from £469.2m; total comprehensive income was £10.3m, including £7.8m FX loss.
Outlook and guidance
Expected divisional dividends of £50m in 2024; five-year estimated dividend and debt-servicing costs total ~£245m, with identified cash sources expected to more than cover them.
Solvency is expected to move toward the 140–160% normal operating range as further M&A is completed.
Positive acquisition pipeline entering 2024, spanning a range of potential deal sizes; financing capacity includes existing cash, debt, equity and revolving credit facility options.
Consumer Duty implementation remained on track for the July 2024 deadline, with no material commercial impact expected.
Latest events from Chesnara
- MetLife UK adds scale and ~£90m lifetime cash flows; completion targeted by end-H1 2027.CSN
M&A announcement - OCG up 79% to £96m, 6% dividend increase, and strong solvency at 185%.CSN
H1 2026 - Major acquisitions and strong capital generation underpin robust growth and future M&A focus.CSN
H2 2025 - Simplified metrics highlight sustainable capital and profit, enhancing transparency and comparability.CSN
Investor presentation - €110m Luxembourg deal adds €1.7bn assets, €250m cash, and boosts European expansion.CSN
M&A announcement - £37m cash generation, 207% solvency, and HSBC Life (UK) acquisition drive growth.CSN
H1 2025 - £260m acquisition and £140m rights issue drive scale, £800m cash flow, and dividend growth.CSN
M&A Announcement - £29.2m cash generation, 3% dividend growth, and 201% solvency highlight robust H1 2024.CSN
H1 2024 - Cash generation up 14%, solvency at 203%, and dividend up 3% with strong M&A momentum.CSN
H2 2024